Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

MERUS LABS INTERNATIONAL INC > Feel sorry for yesterdays buyers....
View:
Post by pacer217 on Aug 11, 2015 9:35am

Feel sorry for yesterdays buyers....

I had a another buy order in Monday for a while at $3.07 and it did not fill; the price ran up on heavy demand to $3.14. I used that little cash to get something else. A poor Q on a terrible market day and this is the result. Probably bounce back in 2 or three months.
Comment by longhaul62 on Aug 11, 2015 9:40am
This might get overdone to the downside because of China.  MSK cites poor results due to currency, and that got a lot more uncertain last night. Could be some fantastic buying opportunities today.
Comment by longhaul62 on Aug 11, 2015 9:41am
MSL, that is
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities